Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 272-745-1 | CAS number: 68910-55-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Substance type: UVCB
- Physical state: powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Limited, Margate, Kent, UK
- Age at study initiation: ca 6-7 weeks
- Weight at study initiation: 201-227 g males; 163-195 g females
- Housing: Housed in polycarbonate cages with stainless steel grid tops and solid bottoms. Animals were initially housed 2/cage by sex. Males were individually housed a few days prior to mating. After mating, males were re-housed with original cage mates.
- Diet (e.g., ad libitum): Rat and Mouse Breeder Diet No. 3 (Expanded) provided ad libitum
- Water (e.g., ad libitum): Public water supply provided ad libitum
- Acclimation period: 9 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-23°C
- Humidity (%): 40-70%
- Air changes (per hr): 10 air changes per hr
- Photoperiod (hrs dark / hrs light): 12 hrs dark / 12 hrs light
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure (if applicable):
- nose only
- Vehicle:
- air
- Details on mating procedure:
- - M/F ratio per cage: 1:1 basis
- Length of cohabitation: Female remained with male until mating had occurred
- Proof of pregnancy: sperm in vaginal smear referred to as Day 0 of pregnancy - Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- Males were treated daily 2 weeks prior to mating, throughout mating, and until the day prior to necropsy (ca. 4 weeks of treatment). Females were treated daily 2 weeks prior to mating, throughout mating, and up to Day 19 of gestation (ca. 6 weeks for treatment).
- Frequency of treatment:
- 6 hr per day, 7 days per week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 5 mg/m³ air (nominal)
- Dose / conc.:
- 50 mg/m³ air (nominal)
- Dose / conc.:
- 300 mg/m³ air (nominal)
- No. of animals per sex per dose:
- 10 animals/sex/dose
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Doses were selected based on the results for a previously performed study.
- Rationale for animal assignment (if not random): Cages were allocated treatment group by the use of randomly sequenced numbers in such a way that each complete rack contained representatives from all treatment groups. - Positive control:
- The study did not include a positive control.
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: One week prior to treatment and weekly thereafter
- Cage side observations included: posture/condition (i.e., prostration, lethargy, writhing, circling, breathing abnormalities, gait abnormalities, tremor, fasciculation, convulsions, biting, vocalizations, and piloerection); ease of removal from the cage; body temperature; condition of the eyes (i.e., pupillary function, miosis, mydriasis, exophthalmos, encrustation, and lacrimation) and coat; presence of salivation, and overall ease of handling.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: One week prior to treatment and daily thereafter
BODY WEIGHT: Yes
- Time schedule for examinations: One week prior to treatment for both sexes. Thereafter, males were weighed twice weekly at the start of dosing until the end of the study. Females were weighed twice weekly at the start of dosing and daily from mating to termination.
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION: No
- Time schedule for examinations: Not reported - Oestrous cyclicity (parental animals):
- Data not reported
- Sperm parameters (parental animals):
- Data not reported
- Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: No
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring: number pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioral abnormalities
GROSS EXAMINATION OF DEAD PUPS:
Yes. Pups dying prior to scheduled necropsy were examined externally and checked for the presence of milk in the study. A macroscopic examination of the tissues and organs of the cranial, thoracic, and abdominal cavities in situ. Pups and their dissected tissues were preserved in 10% neutral buffered formalin. - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving males were sacrificed after mating and treatment for at least 4 weeks.
- Maternal animals: All surviving females were sacrificed between Day 5 and 7 of lactation.
GROSS PATHOLOGY: Yes (see Table 1)
HISTOPATHOLOGY / ORGAN WEIGHTS: Yes; tissues identified in table 1 (except bone marrow smears) were processed from 5 males and 5 females from the control and high-dose groups. - Postmortem examinations (offspring):
- SACRIFICE
- The F1 surviving offspring were scarified between Day 5 and 7 of lactation.
GROSS NECROPSY
- Surviving pups were examined externally for visible abnormalities. Those found to be externally normal were discarded. Pups dying prior to scheduled necropsy were examined externally and checked for the presence of milk in the study. A macroscopic examination of the tissues and organs of the cranial, thoracic, and abdominal cavities in situ. Pups and their dissected tissues were preserved in 10% neutral buffered formalin. - Statistics:
- The following endpoints were analyzed using the 'F Max' test: selected body weight and food consumption data; all hematology, coagulation, and clinical chemistry; and selected functional observational battery and motor activity data. Homogeneous variances were analyzed using a parametric ANOVA. Pairwise comparisons were made using Fisher's F protected LSD method via Student's t test only if the overall F test was significant. Heterogeneous variances were initially transformed using the log or square root. If variances remained heterogeneous, then a Kruskal-Wallis non-parametric ANOVA was used and pairwise compassions were made using chi squared protection.
Organ weight data were analyzed using the methods noted above and through analysis of covariance (ANCOVA) using terminal body weight as the covariate. Organ weight were also analyzed as a percentage of terminal body weight. - Reproductive indices:
- Fertility index (male) = (number siring a litter)/number paired
Fertility index (female) = (number pregnant)/number paired
Gestation index = (number bearing live pups)/number pregnant - Offspring viability indices:
- Birth index = (total number of pups born [live and dead])/number of implantation scars
Live birth index = (number of pups born live on Day 0 of lactation)/(total number born [live and dead])
Viability index = (number of pups live on Day 4 of lactation)/(number live on Day 0)
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, treatment-related
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Other effects:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
Details on results (P0)
ORGAN WEIGHTS: At the high-dose, a statistically significant increase in both absolute and relative lung weight was observed in high-dose males and females. At the mid-dose, there was a statistically significant increase in absolute lung weight for both males and females; however, only females exhibited a statistically significant increase in relative lung weight. No effects on organ weights were observed at the low dose for both males and females.
GROSS PATHOLOGY: There was an increased incidence of dark discoloration of the lungs for all high-dose males and females and dark discoloration of the bronchial lymph node for high-dose males (10/10) and females (9/10). High-dose females also showed an increased incidence of pale foci on the lungs (5/10) and dark discoloration of the mediastinal lymph node (5/10). Mid-dose males (8/10) and females (8/10) showed an increased incidence of dark discoloration of the lungs.
HISTOPATHOLOGY: NON-NEOPLASTIC: At the high-dose, the following treatment-related findings were noted: bronchiolo-alveolar pigmented macrophages/hyperplasia; multifocal alveolar foamy macrophage accumulation; and a higher severity and incidence of mononuclear cell infiltration. In the bronchial lymph node there were pigmented macrophages and increased cellularity. In the mediastinal lymph node, there were pigmented macrophages. A microscopic examination was not conducted at 0.05 and 0.005 mg/L.
Effect levels (P0)
- Dose descriptor:
- NOAEC
- Remarks:
- reproductive
- Effect level:
- 300 mg/m³ air
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: lack of effect
Target system / organ toxicity (P0)
- Critical effects observed:
- no
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- mortality observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings:
- not specified
Details on results (F1)
BODY WEIGHT (OFFSPRING): At the low- and high-dose groups, litter weight on Day 4 of lactation were slightly lower than controls. This was mainly due to one dam in each group that had only one pup remaining. When these animals were removed for the group calculations, group male litter weights were comparable to the control values.
Effect levels (F1)
- Dose descriptor:
- NOEC
- Generation:
- F1
- Effect level:
- > 300 mg/m³ air
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: no adverse effect
Target system / organ toxicity (F1)
- Critical effects observed:
- no
Overall reproductive toxicity
- Reproductive effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- In a combined repeated dose toxicity study with the reproduction/developmental toxicity screening test (OECD 422) inhalation toxicity study, organolignite was administered to 10 Sprague-Dawley rats/sex/concentration by nose only exposure at concentrations of 0, 5, 50, or 300 mg/m3 for 6 hours per day, 7 days/week. There were no treatment-related effects on mating, pregnancy performance, fertility, maternal care, or pup performance. The reproductive NOAEC is 300 mg/m3 based on the lack of effect.
- Executive summary:
In a combined repeated dose toxicity study with the reproduction/developmental toxicity screening test (OECD 422) inhalation toxicity study, organolignite was administered to 10 Sprague-Dawley rats/sex/concentration by nose only exposure at concentrations of 0, 5, 50, or 300 mg/m3 for 6 hours per day, 7 days/week. Males were treated daily 2 weeks prior to mating, throughout mating, and until the day prior to necropsy (ca. 4 weeks of treatment). Females were treated daily 2 weeks prior to mating, throughout mating, and up to Day 19 of gestation (ca. 6 weeks for treatment).
There were no treatment-related effects on mating, pregnancy performance, fertility, maternal care, or pup performance. The systemic NOAEC is 300 mg/m3 (equivalent to 0.3 mg/L; i.e., the high dose) based on a lack of adverse effect. The reproductive NOAEC is 300 mg/m3 (i.e., 0.3 mg/L) based on the lack of effect.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Hoewel ECHA veel materiaa in uw taal online heeft, is een deel van deze pagina in het Engels. Meer informatie van ECHA over meertaligheid.
Welkom op de ECHA-website. In Internet Explorer 7 (en vroegere versies) wordt deze site niet volledig ondersteund. U schakelt het best op een recentere versie van Internet Explorer over.
Deze website maakt gebruik van cookies om het surfen zo aangenaam mogelijk te maken.
Lees meer over hoe wij cookies gebruiken.